Tanshinone IIA Alleviates Early Brain Injury after Subarachnoid Hemorrhage in Rats by Inhibiting the Activation of NF-κB/NLRP3 Inflammasome

• Published in: Biological & pharmaceutical bulletin Vol. 47; no. 1; pp. 279 - 291
• Main Authors: Yang, Fanhui, Ma, Ningshuai, Li, Suping, Chen, Fei, Huang, Xiaohong, Zhao, Li, Cao, Lingzhi
• Format: Journal Article
• Language: English
• Published: Japan The Pharmaceutical Society of Japan 26.01.2024; Japan Science and Technology Agency
• Subjects: Abietanes; Animals; Apoptosis; Brain Injuries - pathology; Brain injury; Cardiovascular system; DNA nucleotidylexotransferase; early brain injury; Edema; Hematoma; Immunofluorescence; Inflammasomes; Inflammasomes - metabolism; Inflammation; Interleukin 6; Monocyte chemoattractant protein; Monocyte chemoattractant protein 1; Monocytes; neuron; NF-kappa B - metabolism; NF-κB protein; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism; nod-like receptor family-pyrin domain-containing 3 (NLRP3); nuclear factor-kappa B (NF-κB); Pyrin protein; Rats; Rats, Sprague-Dawley; Signal transduction; Subarachnoid hemorrhage; Subarachnoid Hemorrhage - complications; Subarachnoid Hemorrhage - drug therapy; Subarachnoid Hemorrhage - pathology; tanshinone IIA; Tanshinones; Traumatic brain injury; Tumor necrosis factor-TNF; neuron; nod-like receptor family-pyrin domain-containing 3 (NLRP3); tanshinone IIA; nuclear factor-kappa B (NF-κB); subarachnoid hemorrhage; early brain injury
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.b23-00519

The abnormal activation of the nuclear factor-kappa B (NF-κB)/nod-like receptor family-pyrin domain-containing 3 (NLRP3) signaling pathway is closely related to early brain injury after subarachnoid hemorrhage (SAH). Targeting the NLRP3-inflammasome has been considered an efficient therapy for the local inflammatory response after SAH. Tanshinone IIA (Tan IIA), a major component extracted from Salvia miltiorrhiza, has been reported to have anti-inflammatory effects. The aim of this study was to investigate the effect and mechanism of Tan IIA on early brain injury after SAH. In vivo SAH injury was established by endovascular perforation technique in Sprague–Dawley rats. Limb-placement test and corner turning test were used to measure the behavior. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining, hematoxylin–eosin (H&E) staining, and immunofluorescence were used to evaluate the nerve damage. Real-time RT quantitative PCR (RT-qPCR) was used to quantify the levels of inflammatory factors. Western blot was performed for the activation of the NF-κB/NLRP3 pathway. An in vitro SAH model was used to validate the conclusion. We found that the neurobehavioral impairment and cerebral edema in SAH model rats given Tan IIA were alleviated. Further study demonstrated that Tan IIA could inhibit SAH-secondary neuronal apoptosis around hematoma and alleviate brain injury. Tan IIA down-regulated the expression of interleukin-6 (IL)-6, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor (TNF)-α, and inhibited the activation of NF-κB. And the overexpression of pro-inflammatory factors NLRP3, IL-1β, and IL-18 induced after SAH was also reversed by Tan IIA. In conclusions, Tan IIA could inhibit the NF-κB/NLRP3 inflammasome activation to protect and ameliorate SAH-followed early brain injury, and may be a preventive and therapeutic strategy against SAH.